Home Mesothelioma Asbestos Mesothelioma Treatment Legal Guide Getting Help News Blog Contact Us
1-877-273-4498
Call Now for Expert Advice
 
 
You Are Here: Mesothelioma.net Blog > 2009 > June

Archive for June, 2009

Asbestos, Canada’s Major Export, Receives Public Scrutiny

Monday, June 22nd, 2009

At one point in time, Canada thought that asbestos was their ticket to prosperity. They even called it the “magic mineral”, and began mining it extensively throughout the country, particularly in Quebec. Unfortunately, in the 1960s when asbestos miners began to show physical signs of asbestos disease, the excitement died down. Canada, like many other developed countries, has spent the last 20-plus years trying to rid homes, schools, and offices of the asbestos insulation that was so freely used.

According to CBC News in Canada, hospitals are still dealing with the after-affects of asbestos use. In 2007, a Sarnia, Ontario clinic registered a new patient almost every day with asbestos-related cancer, such as mesothelioma. This southwestern Ontario city is home to a major petrochemical complex that includes companies such as Imperial Oil, Suncor, and Shell. There are thousands of pipes running through the area that were covered with asbestos insulation and many remain. Quebec is home to the majority of Canada’s asbestos mines and has one of the highest rates of mesothelioma in the world.

Still Mining Asbestos

In spite of the known dangers of asbestos, Canada still continues to mine the mineral and is the second largest exporter after Russia. The bulk of asbestos is shipped to developing countries such as India and China.

There is support for an asbestos ban in Canada. For example, in July 2007, the Canadian Cancer Society called for the government to phase out the use and export of asbestos. Unfortunately, this type of ban would have a devastating effect on the asbestos miners, who still make their living working with this dangerous mineral.

Canada is caught between a rock and a hard place. While the World Health Organization has labeled all types of asbestos as carcinogenic, most developing countries have banned asbestos completely, and the United States announces plans to ban asbestos use in our own manufacturing, Canada continues to support asbestos mining. Unfortunately, the industry is floundering and the Canadian exports are down to less than 25 percent of its original number during its “hey day”.

In addition to the controversy over asbestos and the associated diseases, other factors are causing Canada issues. Transportation costs continue to rise and there are other countries that can sell asbestos more cheaply, like Zimbabwe.

It looks like the asbestos industry in Canada is at risk. While this is good news for proponents of asbestos bans, it does pose issues for the country economically.


Location Announced for 2009 International Symposium on Malignant Mesothelioma

Wednesday, June 17th, 2009

The Mesothelioma Applied Research Foundation will hold its 2009 International Symposium on malignant mesothelioma at the Omni Shoreham Hotel in Washington, DC from June 25 to 27, 2009. The symposium is open to anyone who is interested in learning more about mesothelioma, including patients, caregivers, volunteers, advocates, and medical and scientific experts.

Each of the three days is dedicated to a specific topic as follows:

  • Day One – Advocacy. Meetings will be scheduled with the offices of your House Representatives and Senators. Those attending are encouraged to discuss funding for more research for mesothelioma, as well as federal support to ban asbestos
  • Day Two – Renewing the Spirit. This day is focused on support for those impacted by mesothelioma and will include a ceremony to remember lost loved ones. The day ends with discussions about mesothelioma, including nutrition, genetics, pain management, and medical care.
  • Day Three – Treatment. Clinicians and researchers will present the latest strategies regarding mesothelioma treatment.

For more information on the Symposium, or to register for the event, please go to the Mesothelioma Applied Research Foundation web site.


OSHA Fines Oregon City for Asbestos Violation

Thursday, June 11th, 2009

The Oregon Occupational Safety and Health Administration (OSHA) fined the city of Central Point for not providing appropriate protection from asbestos exposure to workers. Asbestos exposure is the primary cause of mesothelioma, as well as asbestosis. The city employees were working on a demolition project that was completed in February. While only trace amounts of asbestos were found, OSHA fined the city $815 for violating procedural rules regarding training and handling of asbestos, in particular, for not testing the site prior to beginning the demolition.

OSHA started a new initiative in January of this year to enforce the appropriate training of employees and supply of appropriate protective equipment. Companies will be penalized by OSHA for not adhering to these requirements and may receive a separate penalty for each training and equipment violation. OSHA’s addendum is meant to enforce proper punishment again employers who choose to ignore these important safety standards.

For more information on the final ruling, go to the OSHA web site and read the clarification of employer duty.


New Mesothelioma Treatment Shows Early Success

Monday, June 8th, 2009

A new outpatient treatment for mesothelioma victims showed signs of success in a woman who was exposed to asbestos in her childhood. She was diagnosed with mesothelioma in 2008 and did not respond to the conventional chemotherapy treatment. This prompted her to visit NeoPlas Innovation in Nashville, Tennessee.

After two months of treatment under this new protocol, CT scans showed the cancer was stabilizing, larger tumors were shrinking, and her overall condition improved. While these results are early and conclusions cannot yet be drawn, they are similar to the protocol’s success against other aggressive cancers.

The protocol is offered for those patients who qualify and have colon cancer, kidney cancer, pancreatic cancer, melanoma, or certain sarcomas.

This treatment is a combination of two existing medications: lovastatin and interferon. While lovastatin is typically used to lower cholesterol, prior tests proved that it had a significant effect against mesothelioma cells in laboratory cultures.

For more information, visit the NeoPlas web site or read the press release


Research Findings on Mesothelioma Treatment Drug ALIMTA

Monday, June 1st, 2009

Eli Lilly will reveal approximately 50 studies at the end of the month at the 44th Annual Meeting of the American Society of Clinical Oncology in Orlando, Florida. The majority of the 50 presentations will support Lilly’s ongoing study in thoracic cancer research.

Among the notable bits of information to be discussed are the latest research findings on ALIMTA, which is pemetrexed (a chemotherapy drug) for injection. ALIMTA, a treatment for malignant pleural mesothelioma, is given with cisplatin, another chemotherapy drug, when surgery is not an option.
For more information, including a listing of studies of note for ALIMTA and the times they will be presented, see Eli Lilly’s press release


 
 
 
Free Mesothelioma
Information Guide

Instant Download

More Details »

 

Please fill the form below:

First*
Last*
Email
Phone*
Address
City
State
Zip
Please Type*
 
 

Mesothelioma

About the Disease
Types
Risk Factors
Causes
Diagnosis
Signs and Symptoms
Stages
Facts and Statistics
Common Victims

Asbestos

About Asbestos
Asbestos Diseases
Asbestos and Mesothelioma
Asbestos Resources
History of Asbestos
Asbestos Still a Threat
Industries Affected
Asbestos Removal

Treatment

Prevention
Treatment Options
Obtaining Treatment

Legal Guide

Where do I Start
Legal Information

Getting Help

Patient Resources
Financial Resources
Caregiver Resources
Personal Stories
How You Can Help

    Simon, Eddins & Greenstone, LLP (C) 2009.
Created by WSI.
Sitemap | Privacy Statement | Terms of Use | Contact